Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
BCL2 G101V
i
Other names:
BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Associations
(4)
News
Trials
C3 | Sensitive
D | Sensitive
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
BCL Inhibitors
CD Protein Inhibitors
Immunotherapy
Cancel
Chronic Lymphocytic Leukemia
venetoclax + rituximab
C3
BCL2 G101V
|
Chronic Lymphocytic Leukemia
|
venetoclax + rituximab
venetoclax + obinutuzumab
C3
BCL2 G101V
|
Chronic Lymphocytic Leukemia
|
venetoclax + obinutuzumab
BGB-11417
D
BCL2 G101V
|
Chronic Lymphocytic Leukemia
|
BGB-11417
venetoclax
D
BCL2 G101V
|
Chronic Lymphocytic Leukemia
|
venetoclax
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
